Pfizer Provides Update on Phase 3 Study of Investigational Gene Therapy for Ambulatory Boys with Duchenne Muscular Dystrophy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. ASML
2. USO
3. LAD
4. ROIV
5. DKNG
6. BSX
7. ODFL
8. NVS
9. AHR
10. ALV

Go back to Pfizer Provides Update on Phase 3 Study of Investigational Gene Therapy for Ambulatory Boys with Duchenne Muscular Dystrophy
Pfizer Inc. (NYSE: PFE) Delayed: 28.45 --0 (-0%)
Previous Close $28.45    52 Week High $37.39 
Open $28.45    52 Week Low $28.25 
Day High $28.45    P/E 17.24 
Day Low $28.45    EPS $1.65 
Volume 36,470       

Pfizer Inc. (NYSE: PFE) Delayed: 28.45 --0 (-0%)
Previous Close $28.45    52 Week High $37.39 
Open $28.45    52 Week Low $28.25 
Day High $28.45    P/E 17.24 
Day Low $28.45    EPS $1.65 
Volume 36,470